Literature DB >> 33737586

Exploring dementia and neuronal ceroid lipofuscinosis genes in 100 FTD-like patients from 6 towns and rural villages on the Adriatic Sea cost of Apulia.

Celeste Sassi1,2, Rosa Capozzo3, Monia Hammer4, Chiara Zecca3, Monica Federoff4, Cornelis Blauwendraat4, Nick Bernstein4, Jinhui Ding4, J Raphael Gibbs4, Timothy Price4, Andrew Singleton4, Giancarlo Logroscino3,5.   

Abstract

Frontotemporal dementia (FTD) refers to a complex spectrum of clinically and genetically heterogeneous disorders. Although fully penetrant mutations in several genes have been identified and can explain the pathogenic mechanisms underlying a great portion of the Mendelian forms of the disease, still a significant number of families and sporadic cases remains genetically unsolved. We performed whole exome sequencing in 100 patients with a late-onset and heterogeneous FTD-like clinical phenotype from Apulia and screened mendelian dementia and neuronal ceroid lipofuscinosis genes. We identified a nonsense mutation in SORL1 VPS domain (p.R744X), in 2 siblings displaying AD with severe language problems and primary progressive aphasia and a near splice-site mutation in CLCN6 (p.S116P) segregating with an heterogeneous phenotype, ranging from behavioural FTD to FTD with memory onset and to the logopenic variant of primary progressive aphasia in one family. Moreover 2 sporadic cases with behavioural FTD carried heterozygous mutations in the CSF1R Tyrosin kinase flanking regions (p.E573K and p.R549H). By contrast, only a minority of patients carried pathogenic C9orf72 repeat expansions (1%) and likely moderately pathogenic variants in GRN (p.C105Y, p.C389fs and p.C139R) (3%). In concert with recent studies, our findings support a common pathogenic mechanisms between FTD and neuronal ceroid lipofuscinosis and suggests that neuronal ceroid lipofuscinosis genes should be investigated also in dementia patients with predominant frontal symptoms and language impairments.

Entities:  

Year:  2021        PMID: 33737586     DOI: 10.1038/s41598-021-85494-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  44 in total

1.  Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.

Authors:  Michael E Ward; Robert Chen; Hsin-Yi Huang; Connor Ludwig; Maria Telpoukhovskaia; Ali Taubes; Helene Boudin; Sakura S Minami; Meredith Reichert; Philipp Albrecht; Jeffrey M Gelfand; Andres Cruz-Herranz; Christian Cordano; Marcel V Alavi; Shannon Leslie; William W Seeley; Bruce L Miller; Eileen Bigio; Marek-Marsel Mesulam; Matthew S Bogyo; Ian R Mackenzie; John F Staropoli; Susan L Cotman; Eric J Huang; Li Gan; Ari J Green
Journal:  Sci Transl Med       Date:  2017-04-12       Impact factor: 17.956

2.  Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage.

Authors:  Katherine R Smith; John Damiano; Silvana Franceschetti; Stirling Carpenter; Laura Canafoglia; Michela Morbin; Giacomina Rossi; Davide Pareyson; Sara E Mole; John F Staropoli; Katherine B Sims; Jada Lewis; Wen-Lang Lin; Dennis W Dickson; Hans-Henrik Dahl; Melanie Bahlo; Samuel F Berkovic
Journal:  Am J Hum Genet       Date:  2012-05-17       Impact factor: 11.025

3.  Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.

Authors:  Andrew E Arrant; Vincent C Onyilo; Daniel E Unger; Erik D Roberson
Journal:  J Neurosci       Date:  2018-01-29       Impact factor: 6.167

4.  Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement.

Authors:  Rita João Guerreiro; Ebba Lohmann; José Miguel Brás; Jesse Raphael Gibbs; Jonathan D Rohrer; Nicole Gurunlian; Burcu Dursun; Basar Bilgic; Hasmet Hanagasi; Hakan Gurvit; Murat Emre; Andrew Singleton; John Hardy
Journal:  JAMA Neurol       Date:  2013-01       Impact factor: 18.302

5.  Atypical frontotemporal dementia as a new clinical phenotype of Gerstmann-Straussler-Scheinker disease with the PrP-P102L mutation. Description of a previously unreported Italian family.

Authors:  Anna Rita Giovagnoli; Giuseppe Di Fede; Anna Aresi; Fabiola Reati; Giacomina Rossi; Fabrizio Tagliavini
Journal:  Neurol Sci       Date:  2008-11-21       Impact factor: 3.307

6.  Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Cinzia Gellera; Cinzia Tiloca; Roberto Del Bo; Lucia Corrado; Viviana Pensato; Jennifer Agostini; Cristina Cereda; Antonia Ratti; Barbara Castellotti; Stefania Corti; Alessandra Bagarotti; Annachiara Cagnin; Pamela Milani; Carlo Gabelli; Giulietta Riboldi; Letizia Mazzini; Gianni Sorarù; Sandra D'Alfonso; Franco Taroni; Giacomo Pietro Comi; Nicola Ticozzi; Vincenzo Silani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-11-08       Impact factor: 10.154

Review 7.  Motor neuron disease and frontotemporal dementia: sometimes related, sometimes not.

Authors:  John Hardy; Ekaterina Rogaeva
Journal:  Exp Neurol       Date:  2013-11-15       Impact factor: 5.330

Review 8.  Phenotypic signatures of genetic frontotemporal dementia.

Authors:  Jonathan D Rohrer; Jason D Warren
Journal:  Curr Opin Neurol       Date:  2011-12       Impact factor: 5.710

9.  The prevalence of frontotemporal dementia.

Authors:  E Ratnavalli; C Brayne; K Dawson; J R Hodges
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

10.  Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTD.

Authors:  Julie van der Zee; Peter Mariën; Roeland Crols; Sara Van Mossevelde; Lubina Dillen; Federica Perrone; Sebastiaan Engelborghs; Jo Verhoeven; Tine D'aes; Chantal Ceuterick-De Groote; Anne Sieben; Jan Versijpt; Patrick Cras; Jean-Jacques Martin; Christine Van Broeckhoven
Journal:  Neurol Genet       Date:  2016-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.